SolventumMEX:SOLV 23 Interest Coverage is 1.27 as of Mar. 2026, which is 100% below its 10-year median of 10,000.00. GuruFocus rates MEX:SOLV with a GF Score™ of 23/100. The stock has 8 warning signs investors should review. Among 466 Medical Devices & Instruments companies, Solventum ranks worse than 90.34% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Solventum's
Operating Income
for the
three
months ended in Mar. 2026 was MXN1,425 Mil. Solventum's Interest Expense for the
three
months ended in Mar. 2026 was MXN-1,118 Mil.
Solventum's interest coverage for the quarter that ended in Mar. 2026 was 1.27.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for Solventum's Interest Coverage or its related term are showing as below:
MEX:SOLV'
s Interest Coverage Range Over the Past 10 Years
Min: 1.82 Med: No Debt Max: No Debt
Current: 1.83
MEX:SOLV's Interest Coverage is ranked worse than 90.34% of 466
companies
in the Medical Devices & Instruments industry
Industry Median: 15.875
vs MEX:SOLV: 1.83
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Solventum Interest Coverage Related Terms
Solventum Interest Coverage Historical Data
* Premium members only.
The historical data trend for Solventum's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
MEX:SOLV vs COO, ALGN, BAX: Interest Coverage Comparison
For the Medical Instruments & Supplies subindustry, Solventum's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Solventum Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Solventum's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Solventum's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Solventum (MEX:SOLV) has a Interest Coverage of 1.27 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Solventum and its competitors. This is 100% below median its historical median of 10,000.00. Over the past decade, Solventum's Interest Coverage has ranged from 1.82 to 10,000.00. According to the industry distribution chart, Solventum ranks #421 out of 466 companies in the Medical Devices & Instruments industry, placing it in the top 90.3%.
Is Solventum's Interest Coverage too high?
Solventum's current Interest Coverage of 1.27 is 100% below median its 10-year median of 10,000.00. Over the past 10 years, this metric has ranged from a low of 1.82 to a high of 10,000.00. The Medical Devices & Instruments industry median Interest Coverage is 15.88. Solventum's value of 1.27 is 92% below this industry median. Based on the distribution chart, Solventum ranks #421 out of 466 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Solventum has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Solventum's Interest Coverage compare to COO and ALGN?
According to the Medical Devices & Instruments industry distribution chart, Solventum ranks #421 out of 466 companies for Interest Coverage. This places Solventum in the lower half of its industry. The industry median Interest Coverage is 15.88. Solventum's value of 1.27 is 92% below this benchmark. Historically, Solventum's own Interest Coverage has ranged from 1.82 to 10,000.00 over the past decade. While the company's 10-year median is 10,000.00 vs. the industry median of 15.88, Solventum has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 15.88, based on 466 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Solventum's current Interest Coverage of 1.27 is 92% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Solventum and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 15.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Solventum's current Interest Coverage is 1.27, which is 100% below median its own 10-year median of 10,000.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solventum stock overvalued right now?
Solventum (MEX:SOLV) has a current Interest Coverage of 1.27. The current Interest Coverage is 1.27, which is 100% below median its 10-year median of 10,000.00 and 92% below the Medical Devices & Instruments industry median of 15.88. Solventum's overall GF Score™ is 23/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Solventum (MEX:SOLV), the current Interest Coverage is 1.27 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Solventum Corp is a healthcare company developing, manufacturing, and commercializing solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. Its segments include MedSurg, which earns maximum revenue and provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, providing software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. It operates in the United States, which earns the majority of revenue, and internationally.
23GF Score
Get the complete analysis for MEX:SOLV
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:SOLV has been successfully added to your 
